Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhu Shi has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Jianxia Ke

    Department of Neurology and Stroke Center, Dongguan People’s Hospital, Southern Medical University, Dongguan, Guangdong, People’s Republic of China

    5 shared publications
  • Jinrui Li

    Department of Neurology and Stroke Center, Dongguan People’s Hospital, Southern Medical University, Dongguan, Guangdong, People’s Republic of China

    4 shared publications
  • Jintao Li

    Department of Neurology and Stroke Center, Dongguan People’s Hospital, Southern Medical University, Dongguan, Guangdong, People’s Republic of China

    3 shared publications
  • Junting Chen

    Postgraduate School, Guangdong Medical University, Zhanjiang, Guangdong, People’s Republic of China

    3 shared publications
  • Kailin Cheng

    3 shared publications
  • Xiaoli Fu

    3 shared publications

Latest Publications

  • Open Access

    Differential associations of intracranial large artery phenotypes (calcification vs. stenosis) with topographical white matter hyperintensity patterns in minor stroke/transient ischemic attack (TIA)

    by Jintao Li, Jia Wen, Kailin Cheng, Yazhao Liu, Shuen Li, Xiaoli Fu, Zhu Shi

    Background: White matter hyperintensity (WMH) is a common cerebrovascular complication of hypertension, associated with intracranial arterial diseases, including stenosis and calcification. However, the distinctive pathophysiological mechanism remains unclear. To address this critical knowledge gap, the present study was designed to investigate the impact of major intracranial arterial phenotypes, including stenosis and calcification, on WMH and the differences in WMH across distinctive topological regions. Methods: Consecutive stroke patients from an unicentric cohort were retrospectively enrolled. Major intracranial vessels evaluated included the intracranial segment of the C4–7 segments of internal carotid artery (ICA), M1 of the middle cerebral artery (MCA), V4 of the vertebral artery (VA) and the basilar artery (BA). Intracranial artery calcification (IAC) was determined on non-contrast computed tomography (NCCT) and classified into intimal-IAC and medial-IAC, and the number of involved arteries was recorded; intracranial artery stenosis burden (ICASB) was evaluated using computed tomography angiography (CTA); WMH severity was assessed using the Fazekas score, and categorized as none/mild, moderate and severe. Logistic regression models were constructed to evaluate the relationship between IAC, intracranial arterial stenosis (ICAS) with WMH. Results: Among the 503 enrolled patients (40.6% female; median age 71 years), a higher ICASB was independently associated with greater overall WMH severity [adjusted odds ratio (OR) 1.47 per unit increase, 95% confidence interval (CI): 1.31–1.66; PConclusions: Intracranial arterial stenosis and calcification jointly contribute to WMH; each exhibited subtle heterogeneity in pathogenesis of P-WMH and D-WMH, with medial-IAC being more closely associated with P-WMH.

  • Open Access

    Anti-Metabotropic Glutamate Receptor 5 Autoimmune Encephalitis with a Typical Alzheimer’s Disease Biomarker Profile: A Case of Rapidly Progressive Dementia Unresponsive to Cholinesterase Inhibitors

    by Yazhao Liu, Jianghao Zhao, Zhu Shi

    Introduction: The distinction between neurodegenerative and autoimmune causes of rapidly progressive dementia can be challenging, particularly when atypical Alzheimer’s disease (AD) biomarkers are present. We present a case of anti-metabotropic glutamate receptor 5 (mGluR5) autoimmune encephalitis (AE) initially misdiagnosed as AD due to concordant clinical, imaging, and biomarker findings. Case Presentation: A 51-year-old woman developed progressive memory decline, apathy, and stereotyped paper-folding behavior over 2 years. She was diagnosed with rapidly progressive AD and treated with donepezil and memantine without improvement. Initial workup showed hippocampal neurodegeneration on magnetic resonance imaging/MRS and elevated plasma phosphorylated tau181, tau217, and GFAP – consistent with an AD biomarker profile. Neurological examination later revealed bilateral pyramidal signs. Re-evaluation identified serum anti-mGluR5 antibodies. Treatment with intravenous methylprednisolone and immunoglobulin led to marked improvement in cognition and behavior within 2 weeks. Conclusion: This case demonstrates that anti-mGluR5 AE can manifest with a biomarker profile highly suggestive of AD, leading to prolonged misdiagnosis. It underscores the importance of considering AE in treatment-refractory or atypical dementia, even in the presence of supportive AD biomarkers, and highlights the potential for significant recovery with timely immunotherapy.

  • Open Access

    Brain Frailty on Neuroimaging Beyond Chronological Age Is Associated with Functional Outcome After Endovascular Thrombectomy in Patients with Anterior Large Vessel Occlusion

    by Jinrui Li, Junting Chen, Kailin Cheng, Jianxia Ke, Jintao Li, Jia Wen, Xiaoli Fu, Zhu Shi

    Background: Current guidelines have not recommended an upper age limit for endovascular thrombectomy (EVT) in patients with large vessel occlusion (LVO) stroke. However, elder age links to an increased risk of poor outcome. This study aimed to investigate the efficacy of EVT in elderly versus non-elderly patients and determine the respective factors of poor outcome. Methods: Three hundred and two consecutive patients with LVO-stroke who underwent EVT were included, and we used sensitivity analysis with restricted cubic spline to define 75 years as the inflexion point. Participants were thus dichotomized into elderly (≥ 75 years) and non-elderly (< 75 years) groups. Brain frailty on neuroimaging was evaluated using the global cortical atrophy (GCA) scale and the Fazekas scale for white matter lesions (WML). The primary outcome was 3-month functional outcome, and the secondary outcomes were EVT efficacy and safety. Results: Elderly patients had significantly higher incidences of hypertension, diabetes mellitus, atrial fibrillation, and more severe GCA and WML. The rate of good outcome in elderly patients was 32%, significantly lower than non-elderly patients (54%, p< 0.001). There was no difference in terms of reperfusion (89% vs 93%, p=0.363) and intracranial hemorrhage (38% vs 41%, p=0.826) between two groups. In elderly patients, high degree of GCA (OR 1.15, 95% CI 1.02– 1.30, p=0.012) and moderate/severe WML (OR 5.88, 95% CI 1.47– 23.50, p=0.015) independently predicted 3-month poor outcomes. Conclusion: GCA and WML play pivotal roles for the functional outcomes in elderly patients undergoing EVT for LVO-stroke, providing valuable and practical information for early prediction of long-term prognosis.


  • Open Access

    Heme Oxygenase‐1 Gene (GT)n Polymorphism Linked to Deep White Matter Hyperintensities, Not Periventricular Hyperintensities

    by Junting Chen, Jinrui Li, Xiaomian Wang, Xiaoli Fu, Jianxia Ke, Jintao Li, Jia Wen, Kailin Cheng, Shuen Li, Zhu Shi

    Background: Oxidative stress plays a principal role in the pathogenesis of white matter hyperintensities (WMHs). The induction of heme oxygenase‐1 ( HO‐1 ) gene in the brain represents 1 of the pivotal mechanisms to counteract the noxious effects of reactive oxygen species, and the transcriptional modulation of HO‐1 induction depends on the length of a GT‐repeat (GT)n in the promoter region. We investigated whether the HO‐1 gene (GT)n polymorphism is associated with the risk of WMHs. Methods and Results: A total of 849 subjects from the memory clinic were consecutively enrolled, and the HO‐1 (GT)n genotype was determined. WMHs were assessed with the Fazekas scale and further divided into periventricular WMHs and deep WMHs (DWMHs). Allelic HO‐1 (GT)n polymorphisms were classified as short (≤24 (GT)n), median (25≤[GT]nHO‐1 (GT)n variants on WMHs. The number of repetitions of the HO‐1 gene (GT)n ranged from 15 to 39 with a bimodal distribution at lengths 23 and 30. The proportion of S / S genotypes was higher for moderate/severe DWMHs than none/mild DWMHs (22.22% versus 12.44%; P =0.001), but the association for periventricular WMHs was not statistically significant. Logistic regression suggested that the S / S genotype was significantly associated with moderate/severe DWMHs ( S / S versus non‐ S / S : odds ratio, 2.001 [95% CI, 1.323–3.027]; P HO‐1 gene (GT)n S / S genotype and aging synergistically contributed to the progression of DWMHs (relative excess risk attributable to interaction, 6.032 [95% CI, 0.149–11.915]). Conclusions: Short (GT)n variants in the HO‐1 gene may confer susceptibility to rather than protection from DWMHs, but not periventricular WMHs. Registration: URL: https://www.chictr.org.cn ; Unique identifier: ChiCTR2100045869.


  • Open Access

    Integrated transcriptomic and proteomic profiling reveals the key molecular signatures of brain endothelial reperfusion injury

    by Yabin Ji, Yiman Chen, Xixi Tan, Xiaowen Huang, Qiang Gao, Yinzhong Ma, Shilun Yang, Meifang Yin, Min Yu, Cheng Fang, et al.

    Background: Reperfusion therapy after ischemic stroke often causes brain microvascular injury. However, the underlying mechanisms are unclear.Methods: Transcriptomic and proteomic analyses were performed on human cerebral microvascular endothelial cells following oxygen–glucose deprivation (OGD) or OGD plus recovery (OGD/R) to identify molecules and signaling pathways dysregulated by reperfusion. Major findings were further validated in a mouse model of cerebral ischemia and reperfusion.Results: Transcriptomic analysis identified 390 differentially expressed genes (DEGs) between the OGD/R and OGD group. Pathway analysis indicated that these genes were mostly associated with inflammation, including the TNF signaling pathway, TGF‐β signaling pathway, cytokine–cytokine receptor interaction, NOD‐like receptor signaling pathway, and NF‐κB signaling pathway. Proteomic analysis identified 201 differentially expressed proteins (DEPs), which were primarily associated with extracellular matrix destruction and remodeling, impairment of endothelial transport function, and inflammatory responses. Six genes (DUSP1, JUNB, NFKBIA, NR4A1, SERPINE1, and THBS1) were upregulated by OGD/R at both the mRNA and protein levels. In mice with cerebral ischemia and reperfusion, brain TNF signaling pathway was activated by reperfusion, and inhibiting TNF‐α with adalimumab significantly attenuated reperfusion‐induced brain endothelial inflammation. In addition, the protein level of THBS1 was substantially upregulated upon reperfusion in brain endothelial cells and the peri‐endothelial area in mice receiving cerebral ischemia.Conclusion: Our study reveals the key molecular signatures of brain endothelial reperfusion injury and provides potential therapeutic targets for the treatment of brain microvascular injury after reperfusion therapy in ischemic stroke.


  • Open Access

    A Non-Linear Role of Hyperlipidemia on Progression of Intracranial Atherosclerotic Plaques and Acute Downstream Ischemic Events

    by Jianxia Ke, Jinrui Li, Junting Chen, Chengze Lai, Weicheng Zheng, Xiaoli Fu, Xuewen Fang, Lianxian Guo, Zhu Shi

    Aim: Intracranial atherosclerotic stenosis (ICAS) is the leading cause of ischemic stroke worldwide. Hyperlipidemia is a major contributor to atherosclerosis. However, the effect of hyperlipidemia on the evolution of intracranial atherosclerotic plaques and downstream ischemic episodes remains unclear. In this study, we aimed to assess the radiological features of ICAS plaques and to explore the relationship between hyperlipidemia and plaque progression. Methods: We included people with ICAS (≥50% stenosis) undergoing high-resolution magnetic resonance imaging. The culprit plaque was defined as the sole, or in case of multiple stenosis, the narrowest plaque on the intracranial artery responsible for acute ischemic stroke. Demographic, clinical data, plaque features on MRI, and lipid parameters were compared between culprit and non-culprit plaques. Plaque enhancement was graded as Grade 0, 1 and 2 by comparing to the adjacent normal vessel wall and pituitary funnel after contrast enhancement on T1-weighted sequences. Results: 162 patients were included (mean age 57.7±12.1 years, male 61.6%), 110 of whom were identified as culprit plaque with an ipsilateral acute stroke. High-grade enhancement was the most prominent MRI feature of the culpable plaque (Grade-2: OR 6.539, 95%CI 1.706-23.707, p=0.006). LDL cholesterol was significantly associated with overall acute ischemic stroke caused by culprit plaque. After stratification by enhancement grading LDL was independently associated with ischemic events in Grade-1 enhancement plaques (OR 6.778, 95%CI 2.122-21.649, p=0.001). In patients with Grade-2 enhancement plaques, however, LDL was not associated with ischemic event; in contrast, Neutrophil/Lymphocyte ratio was independently associated with ischemic events caused by Grade-2 enhancement plaques (OR 2.188, 95%CI 1.209-3.961, p=0.010). Conclusions: LDL was related with ischemia events in intermediate stage of intracranial atherosclerotic plaque progression, an excellent period for intensive lipid-lowering treatment. In advanced stage, inflammatory agents maybe the main contributor to ischemic events.


  • Open Access

    Attenuation of cerebral edema facilitates recovery of glymphatic system function after status epilepticus

    by Kewei Liu, Juan Zhu, Yuan Chang, Zhenzhou Lin, Zhu Shi, Xing Li, Xing Chen, Chuman Lin, Suyue Pan, Kaibin Huang

    Status epilepticus (SE) is a neurological emergency usually accompanied by acute cerebral edema and long-term cognitive impairment, and is characterized by neurodegeneration and aberrant hyperphosphorylated tau protein (p-tau) aggregation. The glia-lymphatic (glymphatic) system plays a central role in facilitating the clearance of metabolic waste from the brain, but its relationship with cerebral edema and cognitive dysfunction after SE is unclear. We hypothesized that cerebral edema after SE might impair glymphatic system function through compression, thus leading to impaired removal of metabolic waste, and ultimately affecting long-term cognitive function. Our results showed that glymphatic system function was temporarily impaired, as evidenced by 2-photon imaging, MRI enhancement, imaging of brain sections, and astrocytic water channel aquaporin 4 (AQP4) protein polarization. The severity of cerebral edema on MRI correlated well with glymphatic system dysfunction within 8 days following SE. Moreover, when cerebral edema was alleviated by glibenclamide treatment or genetic deletion of Trpm4 , post-SE glymphatic system function recovered earlier, along with fewer p-tau–deposited neurons and neuronal degeneration and better cognitive function. These findings suggest that SE-induced cerebral edema may cause glymphatic system dysfunction and render the post-SE brain vulnerable to p-tau aggregation and neurocognitive impairment.


  • Open Access

    Adult-onset mitochondrial encephalopathy in association with the MT-ND3 T10158C mutation exhibits unique characteristics: A case report

    by Xiao-Li Fu, Xiang-Xue Zhou, Zhu Shi, Wei-Cheng Zheng

    Mitochondrial diseases are a heterogenous group of multisystemic disorders caused by genetic mutations affecting mitochondrial oxidation function. Brain involvement is commonly found in most cases but rarely as the unique clinical manifestation. Since the knowledge of its clinical manifestation combined with genetic testing is important for preventing misdiagnosis and delay in treatment, we report here how we diagnosed and managed a very unusual case of mitochondrial encephalopathy. We report a 52-year-old woman with recurrent stroke-like episodes carrying the m.10158T>C mutation in the MT-ND3 gene, which is also responsible for fatal infant-onset Leigh syndrome. Despite the common mutation, the present case featured a distinct clinical and neuroimaging manifestation from Leigh syndrome. This patient presented with sudden onset of right-sided hemiparesis and hemilateral sensory disturbance accompanied by a left temporal cluster-like headache and later developed epilepsy during hospitalization, with no other signs suggestive of myopathy, lactate acidosis, or other systemic symptoms. Brain magnetic resonance imaging revealed variable lesions involving multiple cortical and subcortical regions. Furthermore, a negative genetic test obtained from peripheral blood delayed the diagnosis of mitochondrial disease, which was eventually established through second-generation DNA sequencing using biopsied muscle. Based on this report, we suggest that clinicians pursue proper genetic testing for patients when the clinical phenotype is suggestive of mitochondrial diseases.